Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Upjohn UK Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
ISTIN 5 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White to off-white, emerald-shaped tablets engraved AML 5 and breaker score on one side and Pfizer logo on the other side. The 5 mg tablet can be divided into equal halves. |
Each tablet contains amlodipine besilate equivalent to 5 mg amlodipine.
Excipients: For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Amlodipine |
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
PVC-PVDC/Aluminium foil blisters containing 4, 10, 14, 20, 28, 30, 50, 60, 98, 100, 300, 500 tablets.
PVC-PVDC/Aluminium foil blisters in calendar packs containing 28 and 98 tablets.
PVC-PVDC/Aluminium foil blister strips containing 50x1 and 500x1 tablets.
Not all pack sizes may be marketed.
Upjohn UK Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 50622/0033
18th September 1989 / 8th February 2013
| Drug | Countries | |
|---|---|---|
| ISTIN | Ireland, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
